Question 1

How does PT-141 differ from Viagra/sildenafil?

Accepted Answer

PT-141 works through melanocortin receptors in the brain to increase desire. PDE5 inhibitors work peripherally on blood flow. PT-141 addresses desire, not mechanics.

Question 2

Is PT-141 FDA-approved?

Accepted Answer

Yes. Bremelanotide was FDA-approved in June 2019 as Vyleesi for HSDD in premenopausal women.

Question 3

Why is nausea so common?

Accepted Answer

MC4R activation in the brainstem area postrema triggers nausea, particularly with the first dose. This typically diminishes with subsequent use.

What is PT-141 - Peptide Encyclopedia